Virpax Pharmaceuticals

NasdaqCM:VRPX Stock Report

Mkt Cap: US$13.5m

Virpax Pharmaceuticals Financial Health

How is Virpax Pharmaceuticals's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: VRPX's short term assets ($29.4M) exceed its short term liabilities ($2.5M).

Long Term Liabilities: VRPX has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: VRPX is debt free.

Reducing Debt: VRPX had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: VRPX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: VRPX has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 86.9% each year.


Discover healthy companies